ARCHIVES

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

ASBMT Installs New Officers

March 14, 2003

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997